US Patent Issued to NImmune Biopharma on Dec. 23 for "Lanthionine synthetase C-like 2-based therapeutics" (Virginia Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,388, issued on Dec. 23, was assigned to NImmune Biopharma Inc. (Blacksburg, Va.).

"Lanthionine synthetase C-like 2-based therapeutics" was invented by Josep Bassaganya-Riera (Blacksburg, Va.), Adria Carbo Barrios (Blacksburg, Va.), Richard Gandour (Blacksburg, Va.), Julian D. Cooper (Blacksburg, Va.) and Raquel Hontecillas (Blacksburg, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease."

The patent was filed on...